PAREXEL Receives Multiple Industry Recognitions for its Service to the Life Sciences Industry

The recognitions include:

• Forbes “America’s Best Management Consulting Firms”: PAREXEL has been named to the Forbes “America’s Best Management Consulting Firms” list recognizing the top consulting companies across all industries. Results are based on independent survey responses from executives who worked with such firms over the last four years.
• Silver Stevie® Award: PAREXEL was named the winner of the Silver Stevie Award in the Company of the Year – Pharmaceuticals – Large category in the 16^th Annual American Business Awards®. The American Business Awards are the United States’ premier business awards program with more than 3,700 nominations submitted this year for consideration.
• 2018 CRO Leadership Award: PAREXEL received a 2018 CRO Leadership Award from Life Science Leader for meeting or exceeding customer expectations across multiple categories including Capabilities, Compatibility, Expertise, Quality and Reliability. Life Science Leader and Industry Standard Research (ISR) determined the award recipients by surveying participants from pharma and biopharma companies of all sizes who were screened for decision-making influence related to working with contract research organizations (CROs). Seventy CROs were assessed on over 20 performance metrics in ISR’s annual CRO Quality Benchmarking survey.
• CRO Quality Award: PAREXEL achieved second place in the first-ever Association of Clinical Research Professionals (ACRP)-Avoca Group CRO Quality Awards, determined by survey ratings from investigational sites.

“At PAREXEL, we ultimately measure ourselves by the success of our clients in bringing new therapies to market and providing access for patients,” said Jamie Macdonald, Chief Executive Officer at PAREXEL. “These recognitions by notable organizations reinforce our leadership and the dedication, expertise and innovation our people deliver to the life sciences industry each day.”

About PAREXEL International

PAREXEL International Corporation is a world’s leading innovator of biopharmaceutical services. We simplify our clients’ journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. PAREXEL develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries around the world. For more information visit www.PAREXEL.com.

PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180530005078/en/